Abstract
The coagulation cascade is a series of sequential reactions of limited proteolysis of protein factors resulting in generation of thrombin. Thrombin mediates both positive and negative feedback in regulating this cascade by taking part in activation of several factors. Some thrombin inhibitors, by affecting positive feedback, inhibit generation of thrombin itself. In the current study, we used two thrombin inhibitors: argatroban, a low molecular weight reversible competitive inhibitor that binds to the active site, and bivalirudin, a bivalent oligopeptide that blocks the active site and binding center of protein substrates (exosite I). Appearance rate and total amount of thrombin were measured in a thrombin generation assay (TGA) using a fluorescent substrate. We found that argatroban slows the appearance of thrombin and lowers its amount. Bivalirudin also slows appearance of thrombin, but it does not decrease its amount, perhaps because the region being bound to the active site undergoes hydrolysis so that the inhibitor stops binding to thrombin. Many reactions of the coagulation cascade proceed on the surface of phospholipid micelles (PLMs). In the case of argatroban, PLMs do not affect the results of the TGA, whereas for bivalirudin they lower its inhibitory activity. It seems that PLMs stabilize protein complexes (wherein thrombin exosite I is hindered) mediating positive feedback in the coagulation cascade, e.g. complexes of thrombin with factor V and VIII.
Similar content being viewed by others
Abbreviations
- AMC:
-
7-amino-4-methylcoumarin
- FII/V/VII/VIII/IX/X/XI/XII/XIII(a):
-
coagulation factors II/V/VII/VIII/IX/X/XI/XII/XIII (activated)
- PLM:
-
phospholipid micelles
- TGA:
-
thrombin generation assay
References
Macfarlane, R. G. (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier, Nature, 202, 498–499.
Davie, E. W. (2003) A brief historical review of the water-fall/cascade of blood coagulation, J. Biol. Chem., 278, 50819–50832.
Jackson, C. M., and Nemerson, Y. (1980) Blood coagulation, Ann. Rev. Biochem., 49, 765–811.
Page, M. J., and Di Cera, E. (2008) Serine peptidases: classification, structure and function, Cell. Mol. Life Sci., 65, 1220–1236.
Suttie, J. W., and Jackson, C. M. (1977) Prothrombin structure, activation, and biosynthesis, Physiol. Rev., 57, 1–70.
Myles, T., Yun, T. H., Hall, S. W., and Leung, L. L. (2001) An extensive interaction interface between thrombin and factor V is required for factor V activation, J. Biol. Chem., 276, 25143–25149.
Myles, T., Yun, T. H., and Leung, L. L. (2002) Structural requirements for the activation of human factor VIII by thrombin, Blood, 100, 2820–2826.
Von dem Borne, P. A., Meijers, J. C., and Bouma, B. N. (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis, Blood, 86, 3035–3042.
Sadasivan, C., and Yee, V. C. (2000) Interaction of the factor XIII activation peptide with α-thrombin crystal structure of its enzyme–substrate analog complex, J. Biol. Chem., 275, 36942–36948.
Dahlback, B., and Villoutreix, B. O. (2005) The anticoagulant protein C pathway, FEBS Lett., 579, 3310–3316.
Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., and Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the TyrPro-Pro-Trp insertion segment, EMBO J., 8, 3467.
Fenton, J. W., Olson, T. A., Zabrinski, M. P., and Wilner, G. D. (1988) Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition, Biochemistry, 27, 7106–7112.
Bjork, I., and Lindahl, U. (1982) Mechanism of the anti-coagulant action of heparin, Mol. Cell. Biochem., 48, 161–182.
Fenton, J. W., Witting, J. I., Pouliott, C., and Fareed, J. (1989) Thrombin anion-binding exosite interactions with heparin and various polyanions, Ann. N. Y. Acad. Sci., 556, 158–165.
Lee, C. J., and Ansell, J. E. (2011) Direct thrombin inhibitors, Brit. J. Clin. Pharmacol., 72, 581–592.
Warkentin, T. E. (2004) Bivalent direct thrombin inhibitors: hirudin and bivalirudin, Best Pract. Res. Clin. Haematol., 17, 105–125.
Berry, C. N., Girardot, C., Lecoffre, C., and Lunven, C. (1994) Effects of the synthetic thrombin inhibitor argatroban on fibrin-or clot-incorporated thrombin: comparison with heparin and recombinant hirudin, Thromb. Haemost., 72, 381–386.
Romisch, J., Diehl, K. H., Hoffmann, D., Krahl-Mateblowski, U., Reers, M., Stuber, W., and Paques, E. P. (1993) Comparison of in vitro and in vivo properties of rhirudin (HBW 023) and a synthetic analogous peptide, Pathophysiol. Haemost. Thromb., 23, 249–258.
Kikumoto, R., Tamao, Y., Tezuka, T., Tonomura, S., Hara, H., Ninomiya, K., and Okamoto, S. (1984) Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid, Biochemistry, 23, 85–90.
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., and Fenton, J. D. (1990) Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin, Biochemistry, 29, 7095–7101.
Robson, R., White, H., Aylward, P., and Frampton, C. (2002) Bivalirudin pharmacokinetics and pharmacody-namics: effect of renal function, dose, and gender, J. Clin. Pharm. Ther., 71, 433–439.
Hemker, H. C., Al Dieri, R., De Smedt, E., and Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system, Thromb. Haemost., 96, 553–561.
Baglin, T. (2005) The measurement and application of thrombin generation, Brit. J. Haematol., 130, 653–661.
Fischer, A. M., Tapon-Bretaudiere, J., Bros, A., and Josso, F. (1981) Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation, Thromb. Haemost., 45, 51–54.
Nagashima, H. (2002) Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and argatroban I. Effects on thrombin generation, J. Biol. Chem., 277, 50439–50444.
Tanaka, K. A., Szlam, F., Sun, H. Y., Taketomi, T., and Levy, J. H. (2007) Thrombin generation assay and vis-coelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin, Anesth. Analg., 105, 933–939.
Nesheim, M. E., Taswell, J. B., and Mann, K. G. (1979) The contribution of bovine factor V and factor Va to the activity of prothrombinase, J. Biol. Chem., 254, 10952–10962.
Huntington, J. A. (2005) Molecular recognition mechanisms of thrombin, J. Thromb. Haemost., 3, 1861–1872.
Yun, T. H., Baglia, F. A., Myles, T., Navaneetham, D., Lopez, J. A., Walsh, P. N., and Leung, L. L. (2003) Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Iba with thrombin anion-binding exosites I and II, respectively, J. Biol. Chem., 278, 48112–48119.
Witting, J. I., Bourdon, P., Brezniak, D. V., Maragnore, J. M., and Fenton, J. W. (1992) Thrombin-specific inhibition by and slow cleavage of hirulog-1, Biochem. J., 283, 737–743.
Cappiello, M., Vilardo, P. G., Del Corso, A., and Mura, U. (1998) Hirunorms, novel hirudin-like direct thrombin inhibitors, Gen. Pharmacol. Vasc. Syst., 30, 565–568.
DiMaio, J., Gibbs, B., Lefebvre, J., Konishi, Y., Munn, D., Yue, S. Y., and Hornberger, W. (1992) Synthesis of a homologous series of ketomethylene arginyl pseudodipep-tides and application to low molecular weight hirudin-like thrombin inhibitors, J. Med. Chem., 35, 3331–3341.
Macedo-Ribeiro, S., Bode, W., Huber, R., Quinn-Allen, M. A., Kim, S. W., Ortel, T. L., and Fuentes-Prior, P. (1999) Crystal structures of the membrane-binding C2 domain of human coagulation factor V, Nature, 402, 434–439.
Pratt, K. P., Shen, B. W., Takeshima, K., Davie, E. W., Fujikawa, K., and Stoddard, B. L. (1999) Structure of the C2 domain of human factor VIII at 1.5 Å resolution, Nature, 402, 439–442.
Sunnerhagen, M., Forsen, S., Hoffren, A. M., Drakenberg, T., Teleman, O., and Stenflo, J. (1995) Structure of the Ca2+-free GLA domain sheds light on membrane binding of blood coagulation proteins, Nat. Struct. Mol. Biol., 2, 504–509.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N. B. Ustinov, E. G. Zav’yalova, A. M. Kopylov, 2016, published in Biokhimiya, 2016, Vol. 81, No. 3, pp. 361–368.
Rights and permissions
About this article
Cite this article
Ustinov, N.B., Zav’yalova, E.G. & Kopylov, A.M. Effect of thrombin inhibitors on positive feedback in the coagulation cascade. Biochemistry Moscow 81, 242–248 (2016). https://doi.org/10.1134/S0006297916030068
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297916030068